Upregulation of the chemokines Rantes, MCP-I, MIP-Ia and MIP-2 in early infection with Trypanosoma brucei brucei and inhibition by sympathetic denervation of the spleen

Tropical Medicine and International Health

Volumn 4, Issue 2, 1999, Pages 85-92

  Liu, Yajuan ^a   Li, Zhilun ^a   Bakhiet, Moiz ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

African trypanosomiasis; Chemokine; Denervation; MCP; MIP; Rantes

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADRENERGIC SYSTEM; AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; SPLEEN CELL; SYMPATHECTOMY; TRYPANOSOMA BRUCEI;

ANIMALS; CHEMOKINE CCL2; CHEMOKINES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUKOCYTES, MONONUCLEAR; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MONOKINES; RANTES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPLEEN; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; UP-REGULATION;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMA BRUCEI BRUCEI;

EID: 0033043053     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1999.00364.x     Document Type: Article

References (36)

1. Askonas BA (1984) Interference in general immune function by parasite infections; African trypanosomiasis as a model system. Parasitology 88, 633-638.
2. Askonas BA (1985) Macrophages as mediators of immunosuppression in murine African Trypanosomiasis. Current Topics in Microbiology and Immunology 117, 119-127.
3. Bakhiet M, Olsson T, Mhlanga J et al. (1996a) Human and rodent IFN-gamma as a growth factor for Trypanosoma brucei. European Journal of Immunology 26, 1359-1364.
4. Bakhiet M, Jansson L, Buscher P, Holmdahl R, Kristensson K & Olsson T (1996b) Control of parasitaemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4. Journal of Immunology 157, 3518-3526.
5. Barry JD & Turner CMR (1991) The dynamics of antigenic variation and growth of African trypanosomes. Parasitology Today 7, 207-211.
6. Ben-Baruch A, Michiel DF & Oppenheim JJ (1995) Signals and receptors involved in recruitment of inflammatory cells. Journal of Biological Chemistry 270, 11703-11706.
7. Bentivoglio M, Grassi-Zucconi G, Olsson T & Kristensson K (1994) Trypanosoma brucei and the nervous system. Trends in Neurosciences 17, 325-329.
8. Borovvy NK, Sternberg JM, Schreiber D, Nonnengasser C & Overath P (1990) Suppressive macrophages occurring in murine Trypanosoma brucei infection inhibit T-cell responses in vivo and in vitro. Parasite Immunology 12, 233-246.
9. Dagerlind A, Friberg K, Bean AJ & Hokfelt T (1992) Sensitive mRNA detection using unfixed tissue: Combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98, 39-49.
10. Esquifino AI & Cardinali DP (1994) Local regulation of the immune response by the autonomic nervous system. Neuroimmunomodulation 1, 265-273.
11. Goodwin LG, Green DR, Guy MW & Voller A (1972) Immunosuppression during trypanosomiasis. British Journal of Experimental Pathology 53, 40-43.
12. Gray P (1994) The role of chemokines and their receptors in leukocyte activation: In Chemotactic Cytokines: Targets for Therapeutic Development (ed. K Gallagher), Plenum Press, Washington, DC, pp. 118-126.
13. Greenwood BM, Whittle HC & Molyneux DH (1973) Immunosuppression in Gambian trypanosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 67, 846-850.
14. Hadden JW, Madden KM & Middleton E (1970) Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cellular Immunology 1, 583-595.
15. Howard OM, Ben-Baruch A & Oppenheim JJ (1996) Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends in Biotechnology 14, 46-51.
16. Hudson KM, Byner C, Freeman J & Terry RJ (1976) Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis. Nature 264, 256-258.
17. Lorton D, Bellinger D, Ducios M, Felten SY & Feiten DL (1996) Application of 6-hydroxydopamine into the fatpads surrounding the draining lymph nodes exacerbates adjuvants-induced arthritis. Journal of Neuroimmunology 64, 103-113.
18. Lotan M & Schwartz M (1994) Cross talk between the immune system and the nervous system in response to injury: implications for regeneration. FASEB Journal 8, 1026-1033.
19. MacNeil BJ, Jansen AH, Greenbery AH & Nance DM (1996) Activation and selectivity of splenic sympathetic nerve electrical activity response to bactrial endotoxin. American Journal of Physiology 270, 264-270.
20. Madden KS & Livnat S (1991) Catecholamine action and immunologic reactivity: In Psychoneuroimmunology. (eds R Ader DL Felten N Cohen). Academic Press, New York, pp. 283-310.
21. Mansfield JM (1994) T-cell responses to the trypanosome variant surface glycoprotein a new paradigm? Parasitology Today 10, 267-270.
22. Miyagishi R, Kikuchi S, Fukazawa T & Tashiro K (1995) Macrophage inflammatory protein 1-alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. Journal of Neurological Sciences 129, 223-227.
23. Mustafa MI, Diener P, Hojeherg B, Van der Meide P & Olsson T (1991) T cell immunity and interferon-gamma secretion during experimental allergic encephalomyclitis in Lewis rats. Journal of Neuroimmunology 31, 165-177.
24. Olsson T, Bakhiet M, Hojeberg B et al. (1993) CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 72, 715-727.
25. Oppenheim JJ, Zachariac CO, Mukaida N & Matsushima K (1991) Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annual Review in Immunology 9, 617-648.
26. Prieschl EE, Kulmburg PA & Baumruker T (1995) The nomenclature of chemokines. International Archives of Allergy Immunology 107, 473-483.
27. Ransohoff RM, Glabinski A & Tani M (1996) Chemokines in immune-mediated inflammation of the central nervous system. Cytokine and Growth Factor Reviews 7, 35-46.
28. Sanders VM & Munson AE (1985) Norepine and the antibody response. Pharmacological Reviews 37, 229-248.
29. Schall TJ & Bacon KB (1994) Chemokines, leukocyte trafficking, and inflammation. Current Opinion in Immunology 6, 865-873.
30. Scott JM, Pegram RG, Holmes PH et al. (1977) Immunosuppression in bovine trypanosomiasis: field studies using foot-and-mouth disease vaccine and clostridial vaccine. Tropical Animal Health and Production 9, 59-165.
31. Tani M & Ranscholl RM (1994) Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? Brain Pathology 4, 133-143.
32. Vickerman K (1978) Antigenic variation in trypanosomes. Nature 273, 613-617.
33. Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M & Rot A (1993) Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin-8. Proceedings of the National Academy of Sciences of the United States of America 90, 7158-7162.
34. Wolpe SD, Davatelis G & Sherry B (1988) Macrophages secrete a novel heparin-binding protein with inflammatory and nentrophil chemokinetic properties. Journal of Experimental Medicine 167, 570-581.
35. Wolpe SD & Cerami A (1989) Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB Journal 3, 2565-2573.
36. Ye J & Young HA (1997) Negative regulation of cytokine gene transcription. FASEB Journal 11, 825-833.